Eliminating Hepatitis C in the United States
25m
·
JAMA Medical News
·
More than 2 million individuals in the US are chronically infected with hepatitis C, and nearly 15 000 die every year. Antivirals are available but are not reaching the majority of infected individuals. In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Francis S. Collins, MD, PhD, discuss a plan to eliminate hepatitis C included in the Biden-Harris 2024 budget proposal.
Related Content:
- A National Hepatitis C Elimination Program in the United States
- Eliminating Hepatitis C in the United States
- Former NIH Director Francis S. Collins on the New White House Plan to Eliminate Hepatitis C
- Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C
- After 12 Years, NIH Director Francis S. Collins, MD, PhD, Seeks His Next Chapter
- After 12 Years, NIH Director Francis S. Collins Seeks His Next Chapter
The episode Eliminating Hepatitis C in the United States from the podcast JAMA Medical News has a duration of
25:30. It was first published
More episodes from JAMA Medical News
Highlights From the American College of Cardiology’s 2024 Scientific Session
Douglas Drachman, MD, shares late-breaking research from the annual conference of the American College of Cardiology and World Congress of Cardiology in an interview with JAMA Medical News Director Jennifer Abbasi. Dr Drachman—who chaired this year’s conference—is an interventional cardiologist at Massachusetts General Hospital, where he is also director of education in the cardiology division.
Related Content:
- Clinical Highlights From the American College of Cardiology’s 2024 Scientific Session
April 12, 2024 Medical News Summary
Momentum Grows for Disaggregated Asian American Health Data; What Clinicians Need to Know About TikTok
Related Content:
- Researchers Are Working to Disaggregate Asian American Health Data—Here’s Why It’s Long Overdue
- Patients Are Turning to TikTok for Health Information—Here’s What Clinicians Need to Know
AI and Clinical Practice: Using AI to Increase Access to Reliable Health Information
Could generative AI assist in extending access to vulnerable populations and begin to bridge the gap in disparities? In this Q&A, Davey Smith, MD, MAS, an infectious disease specialist and virologist at the University of California, San Diego, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to explore the implications of large language models for improving patient outcomes.
Related Content:
- Will Generative AI Tools Improve Access to Reliable Health Information?
March 2024 Medical News Summary
Measles Is Spreading Again in the US; Questions Surround Blood Tests That Claim to Screen for Multiple Cancers; Study Provides Insight Into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Related Content:
- Measles Cases Are Spreading in the US—Here’s What to Know
- Questions Swirl Around Screening for Multiple Cancers With a Single Blood Test
- NIH Study Provides Long-Awaited Insight Into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
AI and Clinical Practice—The Potential for AI to Enable Speech and Facilitate Full Expression for Individuals With Brain Injuries
AI can understand brain signals linked to the sensory and motor processes involved in speech. In this Q&A, Edward Chang, MD, the chair and professor of neurosurgery at UCSF joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI has the potential to facilitate communication and how close AI development is to being able to translate human emotion.
Related Content:
- Digital Avatars and Personalized Voices—How AI Is Helping to Restore Speech to Patients